DECREASE OF MAJOR CARDIAC EVENTS AND HOSPITALIZATIONS IN DE NOVO HEART TRANSPLANT RECIPIENTS RECEIVING EVEROLIMUS: RESULTS FROM A 12-MONTH, MULTICENTER, RANDOMIZED TRIAL COMPARING EVEROLIMUS WITH MMF | Publicación